(Q37084136)

18 August 2017

1 reference

title

Optimal management of superficial bladder cancer (English)

1 reference

18 August 2017

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

3 December 2022

author name string

J. A. Witjes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827328

3 December 2022

F. M. Debruyne

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827328

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827328

3 December 2022

publication date

1 January 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:027753799190541K?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

https://api.elsevier.com/content/article/PII:027753799190541K?httpAccept=text/plain

3 December 2022

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

European Journal of Cancer

3 December 2022

published in

1 reference

18 August 2017

27

1 reference

18 August 2017

330-333

1 reference

18 August 2017

3

1 reference

Selecting initial therapy for bladder cancer

18 August 2017

2

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Surveillance of stage O, grade I bladder cancer by cytology alone--is it acceptable?

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

The significance of lamina propria invasion on the prognosis of patients with bladder tumors

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Prognostic parameters in superficial bladder cancer: an analysis of 315 cases

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Thiotepa-induced myelosuppression: review of 670 bladder instillations.

3 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Long-term fate of 90 patients with superficial bladder cancer randomly assigned to receive or not to receive thiotepa

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Adverse reactions to the intravesical administration of doxorubicin hydrochloride: report of 6 cases

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Use of intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder: an overview

3 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resectio

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Long-term mitomycin C instillation after transurethral resection of superficial bladder carcinoma: influence on recurrence, progression and survival

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma: final evaluation of a prospective multicenter study with 419 patients

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Intravesical interferon treatment of superficial bladder cancer

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Superficial transitional cell carcinoma of the bladder associated with mucosal involvement of the prostatic urethra: results of treatment with intravesical bacillus Calmette-Guerin

3 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Complications of Bacillus Calmette-Guerin immunotherapy: review of 2602 patients and comparison of chemotherapy complications

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

A randomized controlled study of intravesical alpha-2b-interferon in carcinoma in situ of the bladder

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

Intravesical bacillus Calmette-Guerin therapy for in situ transitional cell carcinoma involving the prostatic urethra

3 December 2022

23

1 reference

https://api.crossref.org/works/10.1016/0277-5379(91)90541-K

3 December 2022

Identifiers

1 reference

release_tnnjmubghzb3zn4r4ouut7glg4

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/tnnjmubghzb3zn4r4ouut7glg4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference